NCT03729076

Brief Summary

The study aims to compare crystalloid co-loading and colloid co-loading in parturients receiving prophylactic phenylephrine infusion during cesarean delivery in terms of the incidence of hypotension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for not_applicable pregnancy

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 2, 2018

Completed
14 days until next milestone

Study Start

First participant enrolled

November 16, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2020

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2020

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

1.1 years

First QC Date

October 28, 2018

Last Update Submit

January 31, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of maternal hypotension

    defined as: Systolic Blood Pressure (SBP) \< 80% of baseline SBP

    during the time period from induction of spinal anesthesia until delivery

Secondary Outcomes (20)

  • incidence of severe hypotension

    during the time period from induction of spinal anesthesia until delivery

  • incidence of symptomatic hypotension

    during the time period from induction of spinal anesthesia until delivery

  • incidence of bradycardia

    during the time period from induction of spinal anesthesia until delivery

  • incidence of Hypertension

    during the time period from induction of spinal anesthesia until delivery

  • Minimum recorded Systolic Blood Pressure (Minimum SBP)

    during the time period from induction of spinal anesthesia until delivery

  • +15 more secondary outcomes

Study Arms (2)

Crystalloid

EXPERIMENTAL

Patients will receive rapid co-load of plasma solution A (PSA) 10ml/kg, from the initiation of spinal anesthesia.

Other: Crystalloid

Colloid

ACTIVE COMPARATOR

Patients will receive rapid co-load of 6% volulyte (HES in acetated electrolyte) 10ml/kg, from the initiation of spinal anesthesia.

Other: Colloid

Interventions

Patients will receive the rapid co-loading with plasma solution A (PSA) 10ml/kg, from the initiation of spinal anesthesia, within 10 minutes.

Crystalloid
ColloidOTHER

Patients will receive the rapid co-loading with 6% volulyte (HES in acetated electrolyte) 10ml/kg, from the initiation of spinal anesthesia, within 10 minutes.

Colloid

Eligibility Criteria

Age20 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParturients
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy, full-term parturients who scheduled to undergo elective cesarean delivery under spinal anesthesia.

You may not qualify if:

  • multiple pregnancy
  • gestational age \< 36 weeks
  • preexisting or pregnancy-induced hypertension
  • Morbid cardiovascular impairments
  • Cerebrovascular disease
  • ⑥ Known fetal anomaly
  • ⑦ Contraindications to spinal anesthesia
  • ⑧ Any sign of onset of labor
  • ⑨ Body weight \< 45 kg or body weight \> 90 kg
  • ⑩ Height \< 145cm or height \> 180cm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

Related Publications (4)

  • Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, Palanisamy A, Sia ATH, Van de Velde M, Vercueil A; Consensus Statement Collaborators. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018 Jan;73(1):71-92. doi: 10.1111/anae.14080. Epub 2017 Nov 1. No abstract available.

    PMID: 29090733BACKGROUND
  • Ripolles Melchor J, Espinosa A, Martinez Hurtado E, Casans Frances R, Navarro Perez R, Abad Gurumeta A, Calvo Vecino JM. Colloids versus crystalloids in the prevention of hypotension induced by spinal anesthesia in elective cesarean section. A systematic review and meta-analysis. Minerva Anestesiol. 2015 Sep;81(9):1019-30. Epub 2014 Dec 11.

    PMID: 25501602BACKGROUND
  • Tawfik MM, Tarbay AI, Elaidy AM, Awad KA, Ezz HM, Tolba MA. Combined Colloid Preload and Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery: A Randomized Controlled Trial. Anesth Analg. 2019 Feb;128(2):304-312. doi: 10.1213/ANE.0000000000003306.

    PMID: 29461392BACKGROUND
  • Doytchinova A, Hassel JL, Yuan Y, Lin H, Yin D, Adams D, Straka S, Wright K, Smith K, Wagner D, Shen C, Salanova V, Meshberger C, Chen LS, Kincaid JC, Coffey AC, Wu G, Li Y, Kovacs RJ, Everett TH 4th, Victor R, Cha YM, Lin SF, Chen PS. Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram. Heart Rhythm. 2017 Jan;14(1):25-33. doi: 10.1016/j.hrthm.2016.09.019. Epub 2016 Sep 23.

    PMID: 27670627BACKGROUND

MeSH Terms

Conditions

Hypotension

Interventions

Crystalloid SolutionsColloids

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Isotonic SolutionsSolutionsPharmaceutical PreparationsComplex MixturesDosage Forms

Study Officials

  • Jin-Tae Kim, MD, PhD

    Seoul National University Hospital, Seoul National University College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 28, 2018

First Posted

November 2, 2018

Study Start

November 16, 2018

Primary Completion

January 8, 2020

Study Completion

January 12, 2020

Last Updated

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations